“Arrowhead‘s Annual Traumatic Brain Injury Conference, set to take place on March 7, 2011 in Washington, D.C. has been organized to bring together individuals from the biopharmaceutical industry, government, military and academia to discuss the challenges and opportunities facing those involved in the research and development and commercialization of new therapies for acute and chronic traumatic brain injury (TBI),” a Medical News TODAY article reported earlier this month.

Attendees will hear from a number of industry professionals and R & D experts, including representatives from the Walter Reed Army Institute of Research, the Shepherd Institute, Banyan Biomarkers, NeuroHealing Pharmaceuticals, and Duke University Medical Center, among others.

Presentations will address the following topics:

1. Animals Models and TBI: Translating Results to the Clinic

2. Designing Effective Clinical Trials

3. Drug Delivery Challenges Facing Developers of TBI Therapies

4. Acute TBI

5. Chronic Neurorehabilitation

6. Neuroprotection

7. Secondary Injury with TBI

8. Biomarkers and Molecular Diagnostics in TBI

The conference will take place on Monday, March 7th at the Executive Conference Center at Library Center in Arlington, VA. For information on attending, click here.